EDN1 and pulmonary arterial hypertension: In the mouse models of HIF pathway alteration treated with belzutifan by Ghosh et al., pulmonary hypertension seems to have been caused by increased endothelin-1, a HIF target and vasoconstrictor, and Cxcl-12, a fibroblast proliferation and idiopathic pulmonary fibrosis promoter.